RL vs ZYME · P/E 24, rev $8.11B vs rev $76.3M
Ralph Lauren Corp Class A (RL) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
RL currently screens at market cap $16.95B and trailing P/E 24.1. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the RL and ZYME stock pages for the full models.
Not investment advice.